GB1472793A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1472793A
GB1472793A GB1373974A GB1373974A GB1472793A GB 1472793 A GB1472793 A GB 1472793A GB 1373974 A GB1373974 A GB 1373974A GB 1373974 A GB1373974 A GB 1373974A GB 1472793 A GB1472793 A GB 1472793A
Authority
GB
United Kingdom
Prior art keywords
compositions
march
aqueous
agents
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1373974A
Other languages
English (en)
Inventor
John B Glen
Roger James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB1373974A priority Critical patent/GB1472793A/en
Priority to IE587/75A priority patent/IE40839B1/xx
Priority to US05/559,880 priority patent/US4056635A/en
Priority to ZA00751806A priority patent/ZA751806B/xx
Priority to CA222,804A priority patent/CA1038764A/en
Priority to NZ177023A priority patent/NZ177023A/xx
Priority to IL46899A priority patent/IL46899A/xx
Priority to DK128675A priority patent/DK128675A/da
Priority to SE7503542A priority patent/SE7503542L/
Priority to AU79536/75A priority patent/AU502164B2/en
Priority to NO751076A priority patent/NO751076L/no
Priority to PH16980A priority patent/PH13553A/en
Priority to BE154864A priority patent/BE827290A/xx
Priority to DE2513797A priority patent/DE2513797C2/de
Priority to FI750941A priority patent/FI750941A7/fi
Priority to FR7509683A priority patent/FR2265357B1/fr
Priority to NLAANVRAGE7503696,A priority patent/NL183079C/xx
Priority to JP50037699A priority patent/JPS50154410A/ja
Publication of GB1472793A publication Critical patent/GB1472793A/en
Priority to US05/834,292 priority patent/US4452817A/en
Priority to KE3052A priority patent/KE3052A/xx
Priority to HK343/80A priority patent/HK34380A/xx
Priority to DO1980002892A priority patent/DOP1980002892A/es
Priority to MY111/81A priority patent/MY8100111A/xx
Priority to US06/497,768 priority patent/US4798846A/en
Priority to NL930084C priority patent/NL930084I2/nl
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1373974A 1974-03-28 1974-03-28 Pharmaceutical compositions Expired GB1472793A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB1373974A GB1472793A (en) 1974-03-28 1974-03-28 Pharmaceutical compositions
IE587/75A IE40839B1 (en) 1974-03-28 1975-03-18 Pharmaceutical compositions
US05/559,880 US4056635A (en) 1974-03-28 1975-03-19 2,6-Diisopropylphenol as an anaesthetic agent
ZA00751806A ZA751806B (en) 1974-03-28 1975-03-21 Pharmaceutical compositions
CA222,804A CA1038764A (en) 1974-03-28 1975-03-21 Anaesthetic composition containing 2,6-diisopropyl phenol
NZ177023A NZ177023A (en) 1974-03-28 1975-03-24 Compositions containing 2,6-diisopropylphenol
IL46899A IL46899A (en) 1974-03-28 1975-03-24 Pharmaceutical compositions comprising 2,6-diisopropylphenol for inducing general anesthesia
DK128675A DK128675A (de) 1974-03-28 1975-03-25 Pharmazeutische zusammensetzung
SE7503542A SE7503542L (cg-RX-API-DMAC10.html) 1974-03-28 1975-03-26
AU79536/75A AU502164B2 (en) 1974-03-28 1975-03-26 Pharmaceutical composition containing 2, 6-diisopropylphenol
NO751076A NO751076L (cg-RX-API-DMAC10.html) 1974-03-28 1975-03-26
PH16980A PH13553A (en) 1974-03-28 1975-03-26 Pharmaceutical compositions containing 2,6 diisopropylphenol and method of use thereof
NLAANVRAGE7503696,A NL183079C (nl) 1974-03-28 1975-03-27 Werkwijze ter bereiding van een preparaat geschikt als anestheticum.
BE154864A BE827290A (fr) 1974-03-28 1975-03-27 Composition pour l'anesthesie generale par voie parenterale
DE2513797A DE2513797C2 (de) 1974-03-28 1975-03-27 Pharmazeutische zusammensetzung
FI750941A FI750941A7 (cg-RX-API-DMAC10.html) 1974-03-28 1975-03-27
FR7509683A FR2265357B1 (fr) 1974-03-28 1975-03-27 Compose anesthesique contenant du 2,6 diisopropyl phenol
JP50037699A JPS50154410A (cg-RX-API-DMAC10.html) 1974-03-28 1975-03-28
US05/834,292 US4452817A (en) 1974-03-28 1977-09-19 Anaesthetic compositions containing 2,6-diisopropylphenol
KE3052A KE3052A (en) 1974-03-28 1980-06-05 Pharmaceutical compositions
HK343/80A HK34380A (en) 1974-03-28 1980-06-26 Pharmaceutical compositions
DO1980002892A DOP1980002892A (es) 1974-03-28 1980-08-01 Composicion farmaceutica
MY111/81A MY8100111A (cg-RX-API-DMAC10.html) 1974-03-28 1981-12-30
US06/497,768 US4798846A (en) 1974-03-28 1983-04-04 Pharmaceutical compositions
NL930084C NL930084I2 (nl) 1974-03-28 1993-06-22 Werkwijze ter bereiding van een preparaat geschiktals anestheticum.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1373974A GB1472793A (en) 1974-03-28 1974-03-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1472793A true GB1472793A (en) 1977-05-04

Family

ID=10028495

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1373974A Expired GB1472793A (en) 1974-03-28 1974-03-28 Pharmaceutical compositions

Country Status (22)

Country Link
US (2) US4056635A (cg-RX-API-DMAC10.html)
JP (1) JPS50154410A (cg-RX-API-DMAC10.html)
AU (1) AU502164B2 (cg-RX-API-DMAC10.html)
BE (1) BE827290A (cg-RX-API-DMAC10.html)
CA (1) CA1038764A (cg-RX-API-DMAC10.html)
DE (1) DE2513797C2 (cg-RX-API-DMAC10.html)
DK (1) DK128675A (cg-RX-API-DMAC10.html)
DO (1) DOP1980002892A (cg-RX-API-DMAC10.html)
FI (1) FI750941A7 (cg-RX-API-DMAC10.html)
FR (1) FR2265357B1 (cg-RX-API-DMAC10.html)
GB (1) GB1472793A (cg-RX-API-DMAC10.html)
HK (1) HK34380A (cg-RX-API-DMAC10.html)
IE (1) IE40839B1 (cg-RX-API-DMAC10.html)
IL (1) IL46899A (cg-RX-API-DMAC10.html)
KE (1) KE3052A (cg-RX-API-DMAC10.html)
MY (1) MY8100111A (cg-RX-API-DMAC10.html)
NL (2) NL183079C (cg-RX-API-DMAC10.html)
NO (1) NO751076L (cg-RX-API-DMAC10.html)
NZ (1) NZ177023A (cg-RX-API-DMAC10.html)
PH (1) PH13553A (cg-RX-API-DMAC10.html)
SE (1) SE7503542L (cg-RX-API-DMAC10.html)
ZA (1) ZA751806B (cg-RX-API-DMAC10.html)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010004A1 (en) 1994-09-28 1996-04-04 Zambon Group S.P.A. Process for the purification of 2,6-diisopropylphenol
GB2298789A (en) * 1994-03-22 1996-09-18 Zeneca Ltd Oil-in-Water pharmaceutical composition containing edetate (EDTA) and preferably propofol(2,6-diisopropylphenol)
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
GB2359747A (en) * 2000-02-29 2001-09-05 Maelor Pharmaceuticals Ltd An anaesthetic formulation comprising micelles and propofol
US6540715B1 (en) 1997-12-22 2003-04-01 Bayer Aktiengesellschaft Method and device for in-situ formulation of a medicinal solution for parenteral application
KR100386397B1 (ko) * 2000-04-19 2003-06-02 센츄론(주) 투명한 프로포폴 주사제
KR100410937B1 (ko) * 1999-06-21 2003-12-18 건일제약 주식회사 프로포폴을 함유하는 혈관주사용 마취제 조성물
US7125909B2 (en) 1994-03-22 2006-10-24 Astrazeneca Uk Limited Sterile parenteral nutrition compositions
RU2316317C2 (ru) * 2001-12-28 2008-02-10 Эм-Джи-Ай Джи-Пи, Инк. Составленные на основе воды фармацевтические композиции водорастворимых пролекарств пропофола

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
MY113046A (en) * 1994-03-22 2001-11-30 Astrazeneca Uk Ltd Pharmaceutical compositions
IT1269977B (it) 1994-07-01 1997-04-16 Archimica Spa Purificazione del propofol
CN100512877C (zh) * 1995-03-17 2009-07-15 曾尼卡有限公司 无菌医药组合物
CN1106192C (zh) * 1995-03-17 2003-04-23 曾尼卡有限公司 含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
ES2306452T3 (es) * 1995-10-17 2008-11-01 Jagotec Ag Aporte de farmacos insolubles.
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
DE19709704C2 (de) 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
CH692322A5 (it) 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
US8853260B2 (en) * 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
ATE370726T1 (de) * 1998-02-10 2007-09-15 Sicor Inc Propofolhaltiges arzneimittel enthaltend sulfite
WO1999040906A2 (en) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU764001B2 (en) 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
AU2001257115B2 (en) 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
WO2001097779A2 (en) 2000-06-16 2001-12-27 Rtp Pharma Inc. Improved injectable dispersions of propofol
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
NZ527408A (en) * 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
JP4127757B2 (ja) * 2001-08-21 2008-07-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信システム、通信端末装置、及びバースト信号送信方法
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
WO2003026632A2 (en) 2001-09-26 2003-04-03 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP3931680B2 (ja) * 2002-02-18 2007-06-20 株式会社日本自動車部品総合研究所 車両の直進判別装置
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
WO2004039360A1 (en) * 2002-10-29 2004-05-13 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
RS54275B1 (sr) * 2002-07-29 2016-02-29 Transform Pharmaceuticals, Inc. Vodeni 2,6-diizopropilfenol farmaceutski sastavi
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
WO2004039326A2 (en) * 2002-10-29 2004-05-13 Transform Pharmaceuticals, Inc. Propofol with cysteine
CN100548980C (zh) * 2002-11-26 2009-10-14 丸石制药株式会社 异吲哚啉衍生物
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
JP2007513199A (ja) 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
JP2008543842A (ja) * 2005-06-14 2008-12-04 バクスター インターナショナル インコーポレイテッド 薬物−薬物相互作用を最小にするための薬学的処方物
US20100048732A1 (en) * 2006-05-30 2010-02-25 Emala Sr Charles W Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation
WO2008008492A2 (en) * 2006-07-13 2008-01-17 University Of Iowa Research Fdtn. Hydrofluoroalkyl phenols having anesthetic properties
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
RU2470907C2 (ru) * 2007-05-09 2012-12-27 Сигничер Терапьютикс, Инк. Терапевтические соединения
WO2008141097A2 (en) 2007-05-09 2008-11-20 Pharmacofore, Inc. Stereoisomers propofol therapeutic compounds
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US20090198145A1 (en) * 2008-02-06 2009-08-06 Chow Harrison Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
EP3206683A4 (en) 2014-10-16 2018-06-13 The Board of Trustees of the Leland Stanford Junior University Novel methods, compounds, and compositions for anesthesia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2104412A (en) * 1931-12-29 1938-01-04 Standard Oil Dev Co Alkyl phenols
GB831071A (en) 1956-04-26 1960-03-23 British Schering Ltd Analgesic compounds
GB803080A (en) 1956-07-06 1958-10-15 Scient Oil Compounding Co Inc Bacteriostatic compositions
US2966442A (en) * 1956-09-20 1960-12-27 American Home Prod Antibiotic compositions
US3476838A (en) * 1958-12-04 1969-11-04 Ethyl Corp Di(2,6-diisopropylphenyl) mono halo phosphite or (thio) phosphate
US3067106A (en) * 1959-04-07 1962-12-04 Foundation For Prosthetic Res Skin treating method and composition

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908869A (en) * 1994-03-22 1999-06-01 Zeneca Limited Propofol compositions containing edetate
GB2298789B (en) * 1994-03-22 1999-12-08 Zeneca Ltd Pharmaceutical compositions
US7125909B2 (en) 1994-03-22 2006-10-24 Astrazeneca Uk Limited Sterile parenteral nutrition compositions
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
GB2298789A (en) * 1994-03-22 1996-09-18 Zeneca Ltd Oil-in-Water pharmaceutical composition containing edetate (EDTA) and preferably propofol(2,6-diisopropylphenol)
CZ297549B6 (cs) * 1994-03-22 2007-02-07 Astrazeneca Uk Limited Sterilní farmaceutický prostredek pro parenterální podání, obsahující propofol a edetát
WO1996010004A1 (en) 1994-09-28 1996-04-04 Zambon Group S.P.A. Process for the purification of 2,6-diisopropylphenol
US5589598A (en) * 1994-09-28 1996-12-31 Zambon Group S.P.A. Process of purification of 2,6-diisopropylphenol
US6540715B1 (en) 1997-12-22 2003-04-01 Bayer Aktiengesellschaft Method and device for in-situ formulation of a medicinal solution for parenteral application
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6534547B1 (en) 1998-10-15 2003-03-18 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
EP1121105A4 (en) * 1998-10-15 2003-05-07 Phoenix Scient Inc PROPOFOL-BASED ANESTHETICS AND THEIR PRODUCTION METHOD
KR100410937B1 (ko) * 1999-06-21 2003-12-18 건일제약 주식회사 프로포폴을 함유하는 혈관주사용 마취제 조성물
WO2001064187A3 (en) * 2000-02-29 2002-01-03 Maelor Pharmaceuticals Ltd Anaesthetic formulations
RU2250101C2 (ru) * 2000-02-29 2005-04-20 Меилор Фармасьютикалз Лимитед Анестезирующие рецептуры
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB2359747A (en) * 2000-02-29 2001-09-05 Maelor Pharmaceuticals Ltd An anaesthetic formulation comprising micelles and propofol
CN100376232C (zh) * 2000-02-29 2008-03-26 梅尔洛制药有限公司 麻醉制剂
KR100386397B1 (ko) * 2000-04-19 2003-06-02 센츄론(주) 투명한 프로포폴 주사제
RU2316317C2 (ru) * 2001-12-28 2008-02-10 Эм-Джи-Ай Джи-Пи, Инк. Составленные на основе воды фармацевтические композиции водорастворимых пролекарств пропофола

Also Published As

Publication number Publication date
JPS50154410A (cg-RX-API-DMAC10.html) 1975-12-12
HK34380A (en) 1980-07-01
NZ177023A (en) 1984-09-28
IE40839B1 (en) 1979-08-29
NL930084I1 (nl) 1993-09-16
NL930084I2 (nl) 1994-10-17
DK128675A (de) 1975-09-29
IL46899A0 (en) 1975-06-25
AU502164B2 (en) 1979-07-12
PH13553A (en) 1980-06-26
KE3052A (en) 1980-06-27
FI750941A7 (cg-RX-API-DMAC10.html) 1975-09-29
SE7503542L (cg-RX-API-DMAC10.html) 1975-09-29
BE827290A (fr) 1975-09-29
DE2513797A1 (de) 1975-10-09
US4452817A (en) 1984-06-05
IE40839L (en) 1975-09-28
AU7953675A (en) 1976-09-30
ZA751806B (en) 1976-02-25
DE2513797C2 (de) 1987-07-30
NO751076L (cg-RX-API-DMAC10.html) 1975-09-30
CA1038764A (en) 1978-09-19
NL7503696A (nl) 1975-09-30
US4056635A (en) 1977-11-01
FR2265357B1 (fr) 1978-08-04
IL46899A (en) 1978-03-10
NL183079C (nl) 1988-07-18
MY8100111A (cg-RX-API-DMAC10.html) 1981-12-31
FR2265357A1 (fr) 1975-10-24
DOP1980002892A (es) 1989-10-04

Similar Documents

Publication Publication Date Title
IE40839B1 (en) Pharmaceutical compositions
AU551241B2 (en) Preparation of liposomal medicaments
JO1250B1 (en) New pharmaceutical preparations
ES549814A0 (es) Un procedimiento para preparar una crema antibacteriana, aplicable por via topica
ES2076279T3 (es) Medicamentos que, como principio activo, contienen acidos carboxilicos con contenido en azufre, asi como su empleo para combatir retrovirus.
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
AU7665687A (en) A micelle containing a hydrophobic pharmaceutically active substance
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
HK26584A (en) Injection solutions containing micelle-forming agents
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
BR8707308A (pt) Composicao fibrinolitica aperfeicoada e processo para a disolucao de coagulos em vasos sanguineos
GR3003355T3 (en) Nicorandil-containing preparation for injection
GB1256723A (cg-RX-API-DMAC10.html)
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
KR890012960A (ko) 결정성 β-락탐 용매화물
GB1492029A (en) 4-oxo-1,4-dihydro-1,6-benzo-(h)-naphthyridine-3-carboxylic acid derivatives useful as anti-bacterial agents and their preparation
KR880012226A (ko) 외 용 제
ES8701490A1 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
GB1451389A (en) Indolobenzazepines
GB923942A (en) New compounds, processes for preparing them and pharmaceutical compositions containing them
GB1454390A (en) Nasal decongestants
KR900004713A (ko) 디아민 유도체 및 그의 제조방법
GB1213154A (en) A process for the solubilization of papaveroline and/or papaveroline tetrabenzoylate
GB1185526A (en) Alkylaminoalkyl Ethers of Cycloalkanols and Process for Preparing Ethers of this Type

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
CTFF Supplementary protection certificate filed

Free format text: SPC/GB93/053, 930602

CTFG Supplementary protection certificate granted

Free format text: SPC/GB93/053, 930817, EXPIRES:20000316

CTFE Supplementary protection certificate entered into force

Free format text: SPC/GB93/053, 950317, EXPIRES:20000316

PE20 Patent expired after termination of 20 years

Effective date: 19950316

SPCE Supplementary protection certificate expired

Free format text: SPC/GB93/053, 20000316